Skip to main content

ADVERTISEMENT

Transcatheter aortic valve replacement

Clinical Images
09/29/2017

Johann Auer, MD1,2;  Michael Grund, MD2;  Rudolf Puschmann, MD3;  Robert Berent, MD4

Johann Auer, MD1,2;  Michael Grund, M...
An 86-year-old female patient was referred for treatment of symptomatic severe aortic stenosis. The heart team decided to perform transfemoral TAVI. A 25 mm valve was implanted, but it migrated low into the left ventricular outflow tract. The...
An 86-year-old female patient was referred for treatment of symptomatic severe aortic stenosis. The heart team decided to perform transfemoral TAVI. A 25 mm valve was implanted, but it migrated low into the left ventricular outflow tract. The...
An 86-year-old female patient...
09/29/2017
Journal of Invasive Cardiology
Original Contribution
07/25/2017

Eileen Gajo, MD1;  Omer Iftikhar, MD2;  Paul J. Pearson, MD3;  Ted Feldman, MD2;  Mayra Guerrero, MD2;  Justin Levisay, MD2;  Michael H. Salinger, MD2

Eileen Gajo, MD1;  Omer Iftikhar, MD2...
We describe safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during TAVR. 
We describe safe utilization of Surgiflo hemostatic gel matrix under fluoroscopic guidance against an inflated balloon in order to achieve closure of a fistulous tract from a femoral artery access site during TAVR. 
We describe safe utilization of...
07/25/2017
Journal of Invasive Cardiology
Original Contribution
03/30/2017

Julia Seeger, MD;  Patrick M√ºller;  Birgid Gonska, MD;  Dominik Scharnbeck, MD;  Sinisa Markovic, MD;  Daniel Walcher, MD;  Wolfgang Rottbauer, MD;  Jochen W√∂hrle, MD

Julia Seeger, MD;  Patrick M√ºller;  ...
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device success, procedural success, and 30-day safety endpoint according to the new Mitral Valve Academic Research Consortium criteria (MVARC) in severe primary and secondary mitral regurgitation (MR) patients.
This study compares early device...
03/30/2017
Journal of Invasive Cardiology
Original Contribution
02/28/2017

Prakash Balan, MD, JD1;  Yelin Zhao, MS1;  Sarah Johnson, ANP1;  Salman Arain, MD1;  Abhijeet Dhoble, MD1;  Anthony Estrera, MD2;  Richard Smalling, MD, PhD1;  Tom C. Nguyen, MD2

Prakash Balan, MD, JD1;  Yelin Zhao, ...
This study compares the STS score’s discriminatory power for transcatheter aortic valve replacement mortality as compared with surgical aortic valve replacement mortality.
This study compares the STS score’s discriminatory power for transcatheter aortic valve replacement mortality as compared with surgical aortic valve replacement mortality.
This study compares the STS...
02/28/2017
Journal of Invasive Cardiology
Commentary
07/22/2016

Thomas P. Koshy, MD and Dharam J. Kumbhani, MD, SM

Thomas P. Koshy, MD and Dharam J. Kum...
The authors offer their opinion on the evolution of balloon aortic valvuloplasty.
The authors offer their opinion on the evolution of balloon aortic valvuloplasty.
The authors offer their opinion...
07/22/2016
Journal of Invasive Cardiology
Original Contribution
07/22/2016

Anirudh Kumar, MD1,3;  David Paniagua, MD1,2;  Ravi S. Hira, MD1,4;  Mahboob Alam, MD1;  Ali E. Denktas, MD1,2; Hani Jneid, MD1,2

Anirudh Kumar, MD1,3;  David Paniagua...
It is unclear whether technical advances and increased operator experience associated with TAVR development have resulted in improved BAV outcomes. We examined the evolution in indications, outcomes, and complications of BAV procedures since...
It is unclear whether technical advances and increased operator experience associated with TAVR development have resulted in improved BAV outcomes. We examined the evolution in indications, outcomes, and complications of BAV procedures since...
It is unclear whether technical...
07/22/2016
Journal of Invasive Cardiology
Clinical Images
07/01/2016

A. Garvey Rene, MD1;  Dinesh Jagasia, MD1;  S. Rasi Wickramasinghe, MD, PhD1;  Nimesh Desai, MD, PhD2;  Wilson Szeto, MD2;  Prashanth Vallabhajosyula, MD2;  Robert H. Li, MD1;  Frank E. Silvestry, MD1;  Jay Giri, MD, MPH1;  Saurabh Jha, MD3;  Howard C. Herrmann, MD1;  Saif Anwaruddin, MD1

A. Garvey Rene, MD1;  Dinesh Jagasia,...
The authors report the development of new ventricular septal defects after TAVR in 4 patients with left ventricular outflow tract calcification; they discuss imaging and post-TAVR management of these patients.   J INVASIVE CARDIOL...
The authors report the development of new ventricular septal defects after TAVR in 4 patients with left ventricular outflow tract calcification; they discuss imaging and post-TAVR management of these patients.   J INVASIVE CARDIOL...
The authors report the...
07/01/2016
Journal of Invasive Cardiology
Original Contribution
04/15/2016

Jose F. Condado, MD1;  Stamatios Lerakis, MD1;  James Stewart, MD1;  Hanna Jensen, MD2;  Travis S. Henry, MD3; Sung Min Ko, MD4;  Arthur Stillman, MD3;  Mohammad H. Rajaei, MD2;  Kreton Mavromatis, MD1;  Chandan Devireddy, MD1;  Eric Sarin, MD2;  Brad Leshnower, MD2;  Robert Guyton, MD2;  Brian Kaebnick, MD1; Vinod H. Thourani, MD2;  Peter C. Block, MD1;  Vasilis Babaliaros, MD1

Jose F. Condado, MD1;  Stamatios Lera...
Balloon sizing can complement multidetector CT for annular sizing in TAVR, especially in patients with moderate/severe annular calcification, borderline annular size, and non-tubular LVOT. 
Balloon sizing can complement multidetector CT for annular sizing in TAVR, especially in patients with moderate/severe annular calcification, borderline annular size, and non-tubular LVOT. 
Balloon sizing can complement...
04/15/2016
Journal of Invasive Cardiology
Commentary
03/29/2016

Paul N. Fiorilli, MD and Saif Anwaruddin, MD

 
Paul N. Fiorilli, MD and Saif Anwarud...
Overall, as the use of TAVR continues to expand, the role for identifying which patients are at a higher risk of an adverse outcome post procedure has become increasingly important.
Overall, as the use of TAVR continues to expand, the role for identifying which patients are at a higher risk of an adverse outcome post procedure has become increasingly important.
Overall, as the use of TAVR...
03/29/2016
Journal of Invasive Cardiology
Original Contribution
03/29/2016

Tomo Ando, MD1;  David P. Slovut, MD, PhD2,3;  Anthony A. Holmes, MD2;  Cynthia C. Taub, MD2

 
Tomo Ando, MD1;  David P. Slovut, MD,...
We assessed the impact of spontaneous echocardiographic contrast on outcomes after TAVR by retrospectively reviewing the medical records of 93 consecutive patients who underwent TAVR at a single center.
We assessed the impact of spontaneous echocardiographic contrast on outcomes after TAVR by retrospectively reviewing the medical records of 93 consecutive patients who underwent TAVR at a single center.
We assessed the impact of...
03/29/2016
Journal of Invasive Cardiology